HSD31 Treatment Patterns of Relapsing-Remitting Multiple Sclerosis within the High Cost Drug Law (RICARTE SOTO LAW) Program in Chile from July 2017 to November 2021

The Ricarte Soto Law (RSL) is a Public Health program that provides universal coverage for high-cost treatment diseases. For Relapsing-Remitting Multiple Sclerosis (RRMS), this is a “rescue” program which covers financial costs of Disease Modifying Treatments (DMT) after first-line immunomodulatorshas failed . It started in July’17 covering Natalizumab and Fingolimod. By July’19 Ocrelizumab, Alemtuzumab and Cladribine were included.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research